Spirosure
The Fenom Pro Asthma Monitor will let clinicians measure the fraction of exhaled nitric oxide in their patient's breath.
Pleasanton, California-based Spirosure (previously known as Spirometrix) has raised $15 million in Series C-2 financing for its breath analysis device, according to a statement.